These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 835933)

  • 1. Short dialysis, middle molecules, and uremia.
    Nolph KD
    Ann Intern Med; 1977 Jan; 86(1):93-7. PubMed ID: 835933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of dialysis. The importance of membrane and middle molecules.
    Cheung AK
    Blood Purif; 1994; 12(1):42-53. PubMed ID: 7986475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease.
    Jhawar S; Singh P; Torres D; Ramirez-Valle F; Kassem H; Banerjee T; Dolgalev I; Heguy A; Zavadil J; Lowenstein J
    PLoS One; 2015; 10(3):e0118703. PubMed ID: 25811877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What we have learned about uremia from peritoneal dialysis.
    Nolph KD
    ASAIO J; 1992; 38(4):745-50. PubMed ID: 1450467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More of the same: improving outcomes through intensive hemodialysis.
    McFarlane PA
    Semin Dial; 2009; 22(6):598-602. PubMed ID: 20017828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching for uremic toxins.
    Dobre M; Meyer TW; Hostetter TH
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):322-7. PubMed ID: 23024165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whither goest Kt/V?
    Gotch FA; Sargent JA; Keen ML
    Kidney Int Suppl; 2000 Aug; 76():S3-18. PubMed ID: 10936795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms.
    Bammens B; Evenepoel P; Verbeke K; Vanrenterghem Y
    Kidney Int; 2003 Dec; 64(6):2238-43. PubMed ID: 14633148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal removal of uremic toxins: can we still do better?
    Eloot S; Ledebo I; Ward RA
    Semin Nephrol; 2014 Mar; 34(2):209-27. PubMed ID: 24780474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Plasma Uremic Solute Levels with Residual Kidney Function in Children on Peritoneal Dialysis.
    Ganesan LL; O'Brien FJ; Sirich TL; Plummer NS; Sheth R; Fajardo C; Brakeman P; Sutherland SM; Meyer TW
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1531-1538. PubMed ID: 34233922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for a New Classification of Solutes of Interest in Chronic Kidney Disease and Hemodialysis.
    Reis T; Hutchison C; de Assis Rocha Neves F; Zawadzki B; Zanella M; Ronco C; Rosner MH
    Blood Purif; 2023; 52(3):242-254. PubMed ID: 36657410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The removal of uremic toxins.
    Dhondt A; Vanholder R; Van Biesen W; Lameire N
    Kidney Int Suppl; 2000 Aug; 76():S47-59. PubMed ID: 10936799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do middle molecules cause uremic intoxication? (Con).
    Kjellstrand CM
    Am J Kidney Dis; 1981 Jul; 1(1):51-6. PubMed ID: 7332001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uremic Toxins and their Relation to Dialysis Efficacy.
    Clark WR; Dehghani NL; Narsimhan V; Ronco C
    Blood Purif; 2019; 48(4):299-314. PubMed ID: 31563911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uremic toxins: do we know enough to explain uremia?
    Vanholder R; Meert N; Schepers E; Glorieux G
    Blood Purif; 2008; 26(1):77-81. PubMed ID: 18182802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and clinical evidence for uremic toxicity.
    Bouré T; Vanholder R
    Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical studies and chronic kidney disease: what did we learn recently?
    Liabeuf S; Neirynck N; Drüeke TB; Vanholder R; Massy ZA
    Semin Nephrol; 2014 Mar; 34(2):164-79. PubMed ID: 24780471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rethinking the peritoneal dialysis prescription: results of recent studies.
    Bargman JM
    Nephrology (Carlton); 2006 Apr; 11(2):85-9. PubMed ID: 16669966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.